These effects, along with a prior report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 guidance the notion of focusing on ACKR3 as a novel strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar disorders. Name your collection: Identify https://wernerq243rcm7.techionblog.com/profile